P&G’s Metamucil for cholesterol-lowering
Executive Summary
FDA will meet with representatives from Proctor & Gamble at an OTC feedback meeting July 25 to discuss the effect of psyllium, the active ingredient in Metamucil, on serum cholesterol levels. The meeting begins at 1 p.m. at the Parklawn building in Rockville, Md.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.